Form 8-K CymaBay Therapeutics, For: Nov 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
CymaBay Therapeutics (CBAY) Tops Q3 EPS by 3c
November 12, 2014 4:24 PM ESTCymaBay Therapeutics (NASDAQ: CBAY) reported Q3 EPS of ($0.44), $0.03 better than the analyst estimate of ($0.47).
For earnings history and earnings-related data on CymaBay Therapeutics (CBAY) click here.
... More


